Skip Navigation


Brain Advance Access originally published online on January 22, 2009
Brain 2009 132(2):285-287; doi:10.1093/brain/awn340
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
132/2/285    most recent
awn340v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Calabresi, P.
Right arrow Articles by Di Filippo, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Calabresi, P.
Right arrow Articles by Di Filippo, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author (2009). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Scientific Commentary

Synaptic plasticity, dopamine and Parkinson's disease: one step ahead

Paolo Calabresi1,2, Nicola Biagio Mercuri2,3 and Massimiliano Di Filippo1,2

1Clinica Neurologica, Università di Perugia, Perugia, Italy 2IRCCS Fondazione S. Lucia, Rome, Italy 3Clinica Neurologica, Università di Roma Tor Vergata, Rome, Italy

Email:calabre@unipg.it

The first 150 words of the full text of this article appear below.

The progressive loss of substantia nigra pars compacta neurons that characterizes Parkinson's disease pathology leads to impaired levels of dopamine in several key structures of the basal ganglia neuronal circuit and subsequent alteration of the thinly regulated balance between activities of the output nuclei—the internal segment of the globus pallidus and the substantia nigra pars reticulata—that is considered essential for normal function of the circuit (Fig. 1A).


Figure Removed (Available Only in the Full Text)
View larger version (45K):



 
Fig. 1 The basal ganglia circuit. Potential implications of the LTP of GABAergic signals onto substantia nigra pars reticulata neurons. (a) During physiological conditions the thinly regulated activity of the direct and indirect pathways controls the activity of the output nuclei. (b) During Parkinson's disease, in the absence of a pharmacological treatment, dopamine deficiency causes overactivity of the indirect pathway and reduced activity of the inhibitory GABAergic direct pathway, disinhibiting the output nuclei and thus causing excessive inhibition of . . . [Full Text of this Article]

 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?